Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

LSD use in the United States: Examining user demographics and their evolution from 2015-2019

View ORCID ProfileJeremy Weleff, Akhil Anand, View ORCID ProfileElizabeth N. Dewey, Brian S. Barnett
doi: https://doi.org/10.1101/2022.12.23.22283883
Jeremy Weleff
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
2Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
DO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeremy Weleff
  • For correspondence: weleffj{at}ccf.org jeremy.weleff{at}yale.edu
Akhil Anand
2Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
3Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, EC-10 Cleveland Clinic, Cleveland, OH, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth N. Dewey
4Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA
5Center for Populations Health Research, Cleveland Clinic, Cleveland, OH, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth N. Dewey
Brian S. Barnett
2Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
3Cleveland Clinic Lerner College of Medicine at Case Western Reserve University, EC-10 Cleveland Clinic, Cleveland, OH, USA
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Lysergic acid (LSD) use has risen in the United States (US) in recent years amid increased interest in therapeutic applications of psychedelics. Despite this, contemporary epidemiological investigations of LSD users are few. To expand the literature on this topic, we sought to characterize past-year LSD users in the US and investigate recent demographic evolution within this population.

Methods Using National Survey on Drug Use and Health (NSDUH) data from 2015-2019, we investigated correlates of past-year LSD use and associated changes over the study period.

Results Past-year LSD use increased by 47% from 2015 to 2019 (0.59% to 0.87%). However, among people reporting past-year hallucinogen use disorder there was no significant proportional increase in LSD users. Notable correlates of LSD use on multivariable analysis were: increased LSD access, lower perceived risk of trying LSD, Asian race, low income, fewer children in the home, history of ever selling drugs, being approached by someone selling drugs in the past month, lack of influence of religious beliefs on decision-making, and past-year suicide attempt among people age 18 and older. We found no associations with unemployment, arrest history, past-year psychological distress, or sexually transmitted infections. From 2015 to 2019, the proportion of respondents reporting past-year LSD use who were pregnant, age 26-34, and married increased. Past-year LSD use among lifetime users of methamphetamine also rose.

Conclusions Though still uncommonly used in the US, LSD’s societal acceptance may be increasing. Overall, LSD does not appear to contribute significantly to the country’s public health problems.

  • - For the last few years, NSDUH data has shown an increase in LSD use

  • - Despite this, rates of reported hallucinogen use disorder have not proportionally increased

  • - Evidence shows increasing societal acceptance for LSD use

  • - The proportion of respondents reporting past-year LSD use who were pregnant, age 26-34, and married increased

  • - Past-year LSD use among lifetime users of methamphetamine also rose

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Study Not Funded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Not Applicable

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Public data. No human research completed.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Not Applicable

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Not Applicable

Footnotes

  • Disclosure Statement Dr. Barnett has received stock options from CB Therapeutics as compensation for advisory services and monetary compensation for editorial work for DynaMed Plus (EBSCO Industries, Inc) and consulting services for Cerebral. The other authors report no potential conflicts of interest.

  • Funding This work was unfunded.

  • Data availability statement Data are publicly available

Data Availability

Publicly available data (NSDUH)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted December 26, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
LSD use in the United States: Examining user demographics and their evolution from 2015-2019
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
LSD use in the United States: Examining user demographics and their evolution from 2015-2019
Jeremy Weleff, Akhil Anand, Elizabeth N. Dewey, Brian S. Barnett
medRxiv 2022.12.23.22283883; doi: https://doi.org/10.1101/2022.12.23.22283883
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
LSD use in the United States: Examining user demographics and their evolution from 2015-2019
Jeremy Weleff, Akhil Anand, Elizabeth N. Dewey, Brian S. Barnett
medRxiv 2022.12.23.22283883; doi: https://doi.org/10.1101/2022.12.23.22283883

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)